Compounds > cyclosporine

cyclosporine and Lymphoma, Large-Cell, Anaplastic

cyclosporine has been researched along with Lymphoma, Large-Cell, Anaplastic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naghashpour, M; Nichols, KE; Olin, RL; Shelly, B; Stadtmauer, EA; Vogl, DT; Wasik, M1
Adibi, A; Azhir, A; Reisi, N; Taheri, D1
Crickx, B; Descamps, V; Fraitag, S; Grossin, M; Mahé, E1
Jin, SY; Kim, HK; Lee, NS; Park, HS; Won, JH; Yang, WI1
Duvic, M; Jones, D; Pielop, JA1

Reviews

1 review(s) available for cyclosporine and Lymphoma, Large-Cell, Anaplastic

ArticleYear
CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab.
    The British journal of dermatology, 2003, Volume: 149, Issue:1

    Topics: Antibodies, Monoclonal; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infliximab; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Psoriasis; Skin Neoplasms

2003

Other Studies

4 other study(ies) available for cyclosporine and Lymphoma, Large-Cell, Anaplastic

ArticleYear
Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis.
    American journal of hematology, 2008, Volume: 83, Issue:9

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Cyclosporine; Daclizumab; Doxorubicin; Ferritins; Humans; Immunoglobulin G; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Killer Cells, Natural; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Prednisone; Recurrence; T-Lymphocyte Subsets; Vincristine

2008
Post transplant anaplastic large T-cell lymphoma.
    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2009, Volume: 20, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Creatinine; Cyclophosphamide; Cyclosporine; Doxorubicin; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, Large-Cell, Anaplastic; Male; Mycophenolic Acid; Postoperative Complications; Prednisone; Vindesine

2009
Posttransplant primary cutaneous Ki-1 (CD30)+/CD56+ anaplastic large cell lymphoma.
    Archives of pathology & laboratory medicine, 2004, Volume: 128, Issue:8

    Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; CD4-Positive T-Lymphocytes; CD56 Antigen; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Doxorubicin; Head and Neck Neoplasms; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Postoperative Complications; Prednisolone; Remission Induction; Scalp; Skin Neoplasms; Vincristine

2004
Transient CD30+ nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment.
    International journal of dermatology, 2001, Volume: 40, Issue:8

    Topics: Adult; Biopsy; Cell Transformation, Neoplastic; Cyclosporine; Dermatitis, Atopic; Humans; Immunohistochemistry; Immunosuppressive Agents; Lymphoma, Large-Cell, Anaplastic; Male; Mycosis Fungoides; Polymerase Chain Reaction; Psoriasis; Skin Neoplasms; Staphylococcal Skin Infections

2001